Venture
Affiliations
Icahn School of Medicine at Mount Sinai
Technologies
Therapeutic
Indication
Biomaterials
Molecular Diagnostic
Website
www.frezent.comAdditional Information
Women Founded
FREZENT Biological Solutions will improve the clinical outcomes in head and neck cancer by developing a novel adjuvant therapeutic, targeting drug-resistant dormant cancer cells.
FREZENT Biological Solutions Team: